The present invention provides a nonostructured device comprising a substrate including nanotroughs therein; and a lipid bilayer suspended on or supported in the substrate. A separation method is also provided comprising the steps of supporting or suspending a lipid bilayer on a substrate; wherein the subtrate comprises nanostructures and wherein the lipid bilayer comprises at least one membrane associated biomolecule; and applying a driving force to the lipid bilayer to separate the membrane associated biomolecule from the lipid bilayer and to drive the membrane associated biomolecule into the nanostructures. A fluidic device for separating particles according to size is provided including a fluidic channel, and a matrix comprising a plurality of protrusions within the fluidic channel, wherein the device provides a driving force to the particles being separated through the fluidic channel; and wherein a flow of the driving force from between the protrusions is divided unequally into a major flow component and a minor flow component, each component flowing between subsequent protrusions in the matrix, such that the average direction of the major flow component is not parallel to the average direction of the driving force, and, when particles are introduced into the matrix, particles having a size less than a predetermined critical size are transported generally in the average direction of the driving force, and particles having a size at least that of the critical size are transported generally in the average direction of the major flow component, thereby separating the particles according to size. Methods for separating particles including steps of separation based on size and affinity are also provided.
|
0. 38. A method for separating particles comprising:
(a) providing a substrate and an array of structures arranged on said substrate, wherein said structures comprise protrusions fixed to said substrate in a predetermined pattern having a gradient property in a given direction across a plane of said substrate;
(b) a first separation step comprising separating said particles by size in two dimensions by flowing said particles through said array of structures in said given direction, the separating of said particles occurring at least in part by virtue of said pattern; and
(c) a second separation step comprising separating said particles by affinity.
0. 1. A nanostructured device comprising:
a substrate including at least one nanotrough therein; and
a lipid bilayer suspended over said at least one nanotrough.
0. 2. The nanostructured device of
0. 3. The nanostructured device of
0. 4. The nanostructured device of
0. 5. The nanostructured device of
0. 6. The nanostructured device of
0. 7. The nanostructured device of
0. 8. The nanostructured device of
0. 9. The nanostructured device of
0. 10. The nanostructured device of
0. 11. A nanostructured device comprising:
a substrate including at least one nanotrough therein; and
at least one lipid bilayer supported in at least one of said at least one nanotroughs so as to allow biomolecules to pass from said at least one lipid bilayer into said at least one respective nanotrough.
0. 12. The nanostructured device of
0. 13. The nanostructured device of
0. 14. The nanostructured device of
0. 15. The nanostructured device of
0. 16. The nanostructured device of
0. 17. The nanostructured device of
0. 18. The nanostructured device of
0. 19. The nanostructured device of
0. 20. A separation method comprising the steps of:
(a) supporting or suspending a lipid bilayer on a substrate; wherein said substrate comprises at least one nanostructure and wherein said lipid bilayer comprises at least one membrane associated biomolecule; and
(b) applying a driving force to said lipid bilayer to separate said at least one membrane associate biomolecule from said lipid bilayer and to drive said at least one membrane associated biomolecule within said lipid bilayer into said at least one nanostructure.
0. 21. The method of
0. 22. The method of
0. 23. The method of
0. 24. The method of
0. 25. The method of
0. 26. The method of
0. 27. The method of
0. 28. The method of
0. 29. The method of
0. 30. The method of
0. 31. The method of
0. 32. The method of
0. 33. The method of
0. 34. The method of
0. 35. The method of
0. 36. The method of
0. 37. The method of
0. 39. The method of
0. 40. The method of
0. 41. The method of
0. 42. The method of
0. 43. The method of
0. 44. The method of
0. 45. The method of
0. 46. The method of
0. 47. The method of
0. 48. The method of
0. 49. The method of
0. 50. The method of
0. 51. The method of
0. 52. The method of
0. 53. The method of
0. 54. The method of
0. 55. The method of
0. 56. The method of
|
exentpolycrylamide polyacrylamide. The biomolecules in the mixture then migrate to the region where the pH is equal to a particular biomolecule's isoelectric point, at which time the charged biomolecule becomes electrically neutral. This technique, combined with subsequent separation by SDS-PAGE, is used in traditional two-dimensional gel electrophoresis. Similar pH gradients may be generated using an array of the present invention including a two-dimensional gradient, using traditional isolectric isoelectric focusing with soluble ampholytes or by using chemical patterning techniques, or immobilization of ampholytes after electrical focusing. Examples of capillary-based isoelectric focusing separation processes suitable for use with the present invention are described in Thorman, Tsai, Michaud, Mosher and Bier, Capillary Isoelectric-Focusing: Effects of Capillary, Geometry, Voltage Gradient and Addition of Linear Polymer, J. Chromatography, 398:75-86 (1987), the entire contents and disclosure of which are hereby incorporated by reference.
For the purposes of the present invention, the term “asymmetric diffusion separation process” refers to a separation process in which steric constraints drive diffusion preferentially in one direction. Examples of asymmetric diffusion separation processes suitable for use with the present invention are described in Van Oudenaarden et al., Science, 285: 1046-1052 (1999), the entire contents and disclosure of which are hereby incorporated by reference.
For the purposes of the present invention, the term “entropic trapping separation process” refers to separations using nanostructured devices of alternating thin and thick regions, with the thin regions being smaller than the radius of gyration of the biomolecule being separated. Under an electrical field, the molecules repeatedly change conformation, costing entropic free energy, thus limiting mobility. An example of an entropic trapping separation process suitable for use with the present invention is described in Han J, Craighead H D, Separation of long DNA molecules in a microfabricated entropic trap array, Science, 288:1026-1029 (2000), the entire contents and disclosure of which is hereby incorporated by reference.
For the purposes of the present invention, the term “hydrophobic interaction chromatography separation process” refers to a technique whereby molecules are partitioned between a hydrophobic matrix and a hydrophilic solvent. The degree of hydrophobicity of the target molecule determines the target molecule's retention time. The array of the present invention may be modified to incorporate a gradient of hydrophobicities or to create a milieu in which the hydrophobicity may be rapidly and reversibly changed, thus providing a driving force for molecular movement.
For the purposes of the present invention, the term “affinity chromatography separation process” refers to a chromatography process that takes advantage of specific chemical interactions between a target molecule and a chromatographic matrix. One of the most widely used forms of affinity chromatography employs immunoaffinity in which an antibody or series of antibodies are immobilized on a support. Other affinity agents include enzymes that interact with specific targets or receptors. Another example of affinity chromatography is a molecular recognition separation process such as the separation of long DNA molecules in a microfabricated entropic trap array. An array of the present invention may be used for both the generation of affinity matrices and for the subsequent use of affinity matrices.
For the purposes of the present invention, the term “enantiomeric resolution separation process” refers to a process to separate organic particles, such as biomolecules by chirality. Enantiomeric resolution is especially important in carbohydrate separations where differences between different glycosides are exclusively enantiomeric. Indeed, common chiral selectors are cyclodextrins used in capillary electrophoresis. Macrocyclic antibiotics and crown ethers are commonly used selectors. Selectors may be used either globally or in zones of an array of the present invention to confer yet another means of separation.
For the purposes of the present invention, the term “capillary electrophoresis separation process” refers to a separation process in which separation takes place in a liquid rather than in a gel matrix. Capillary electrophoresis allows for separations to be done on smaller quantities of material and with improved resolution in comparison to conventional gel electrophoresis processes. The channels in an array of the present invention may be arranged to generate a capillary type arrangement in a second direction following separations based on chemical properties (e.g., IEF, affinity, hydrophobic interaction chromatography or enantiomeric separation) or capillaries may be applied as a third dimension.
For the purposes of the present invention, the phrase “comprises Si” refers to silicon and any silicon complex, compound, etc. that includes silicon, such as SiO2, glass, etc.
For the purposes of the present invention, the term “lipid” refers to conventional lipids, phospholipids, etc.
For the purposes of the present invention, the term “lipid bilayer” refers to any double layer of oriented amphipathic lipid molecules in which the hydrocarbon tails face inward to form a continous continuous nonpolar phase.
For the purposes of the present invention, the term “simple bilayer” refers to a conventional lipid bilayer in which the bilayer is formed from micelles of phospholipids with or without membrane proteins.
For the purposes of the present invention, the term “hybrid bilayer” refers to a bilayer that is derived from more than one source, either through mixing of micelles before formation, or post bilayer fusion. These also refer to bilayers in which one component is synthetically derived, or in which one leaflet is supported on the nanotextured surface prior to bilayer formation.
For the purposes of the present invention, the term “self-assembled monolayer hybrid bilayer” refers to a hybrid bilayer in which the synthetic portion is composed of a self-assembled monolayer of silanes or ω-substituted alkanethilates on gold.
For the purposes of the present invention, the term “suspended” refers to bilayers present on a nanostructure and located above nanotroughs in a nanostructure. An example of a suspended bilayer is shown in
For the purposes of the present invention, the term “supported” refers to bilayers located in nanotroughs of a nanostructure. An example of a supported bilayer is shown in FIG. 12.
For the purposes of the present invention, the term “nanotrough” refers to a trough with a void dimension of 1-500 nm, whether uniform or not.
For the purposes of the present invention, the term “leaflet” refers to one half of a fluid bilayer membrane composed of a single layer of phospholipids and any included proteins.
For the purposes of the present invention, the term “filled with at least one fluid” refers to a nanostructure, preferably a nanotrough or channel, containing a fluid that is at least partially contained within said nanostructure. The nanostructure does not need to be completely filled with a fluid according to this definition.
For the purposes of the present invention, the term “membrane associated biomolecule” refers to any membrane associated biomolecule, such as transmembrane proteins, membrane phospholipids, lipophilic biomolecules, complexes thereof, etc.
The present invention provides, in part, for robust, inexpensive and reproducible methods for forming separation matrices for gradient separations based on, for example, electrophoresis and size exclusion that includes all the positive traits of gradient PAGE. These matrices may be adapted for a host of variant separation strategies, including electrophoresis, detergent solubilization, native electrophoresis, isoelectric focusing, 2D-electrophoresis, hydrophobic interaction, and affinity chromatography. More specifically, the present invention provides for the use of such separation matrices as support for lipid bilayers that serve as separation platforms for membrane-associated biomolecules. The methods of fabrication discussed herein may also be adapted to existing microfabrication and integration facilities.
The present invention provides for separation of molecular species across a nanostructured matrix, a method of fabricating nanostructures comprising the matrix and the use of such a matrix for separation and/or analysis of molecules by defining the physical size and/or chemical features of the nanostructures as a means of screening. The nanostructured matrix may be used to separate biological materials, such as proteins, carbohydrates, and nucleic acids as well as non-biological materials, such as synthetic polymers. These nanostructures may be made out of a variety of materials, including silicon, thus providing systems that may be easily chemically modified for additional flexibility. The use of lithography to generate nanostructured separation matrices has advantages over other techniques (such as traditional acrylamide gel polymerization) since it (1) creates highly ordered structures, (2) gives the possibility of creating macroscopic arrays of continually varying size or chemistry across one dimension, (3) is highly reproducible, and (4) may be easily implemented in the creation of complex, integrated separation systems that are disposable or reusable. Furthermore, the use of lithographically defined separation matrices lends itself to the facile implementation of these matrices into multi-level, 3-dimensional separation devices in which different screening mechanisms allow enhanced separations. Particularly, the lithographic nanostructured surfaces may be used to support lipid bilayers or hybrid lipid bilayers for separating membrane-associated molecules and studying cellular interactions. The present invention aims to (1) eliminate some of the current limitations by the fabrication of highly uniform and reproducible nanostructured separation systems prepared by nano- and microlithography, and (2) eliminate some of the current limitations by utilizing the lithographic nanostructured surfaces in conjunction with lipid bilayers to produce separation platforms for membrane-associated molecules.
Nanolithographically-Defined Gradients:
Using an advanced lithographic technique such as interferometric lithography (IL) capable of producing nanostructures, patterns of nanostructures may be rapidly created over wide, macroscopic areas at low cost (compared to other techniques such as electron beam lithography). In addition, it may be used to easily generate arrays of nanostructures (protrusions or channels) whose dimensions vary semi-continuously in the plane of surface of the material being patterned. IL has advantages over other methods that might be used to construct nanopatterned fluidic structures (e.g., electron beam lithography, X-ray lithography, or local probe lithography) due to the low cost of implementation and the parallel nature of the lithographic technique. Combining IL with conventional lithography allows for the formation of device structures in individual areas and the addition of aperiodic features such as electronic and fluidic connections. Imaging interferometric lithography extends optics to fundamental, deep-subwavelength scales.
It is worthwhile at this point to consider the fundamental limits of optical lithography. For the interference of two plane waves in air, the period is given by λ/(2 sin θ) where λ is the optical wavelength and θ is the angle of incidence. For a 213-nm laser source (fifth harmonic of YAG) this gives a period of ˜150 nm (for θ=80°).
Water and higher-index liquids, including liquid Ar (n˜1.6), may be used to further extend these results into the sub-100-nm period regime that will be important for biological separations.
Nonlinear processes may be used to further reduce the period.
Importantly, all of these results are macroscopic in scale, e.g., covering areas of ˜1 cm2 or larger. A strength of optics is the parallel nature of the exposure, which may be cm's or larger in extent. For a square lattice with a 100-nm pitch and a 1 cm field, there are 1010 features, well beyond the realistic capabilities of serial techniques such as e-beam and scanning probes. In particular embodiments of the present invention, IL may be extended deep into the nanometer regime (either to feature sizes of ˜10 nm or nearest-neighbor distances (aperture sizes) of <10 nm, but not both simultaneously).
A continuously varying channel spacing between nanostructures is desired for many of the bio-separation applications such as various nanofluidic configurations discussed herein.
One approach to a graded structure is to macroscopically vary the intensity across the plane of exposure while keeping the other interference conditions, such as the angles between the light propagation vectors and the polarization, unchanged. One such variation of intensity would be a smooth gradient in intensity of one of the two interfering light waves. This results in interference fringes with uniform spacing but different intensities. The difference in intensity of the fringes leads to differences in exposure of the photoresist used. Because the fringe spacing is not changed, the pitch is uniform. The interference pattern would have even better contrast if both light waves had the same gradient in intensities.
When a positive photoresist is used, the areas corresponding to fringes with stronger intensities leave wider cavities in the photoresist after exposure and developing. The areas corresponding to fringes with weaker intensities leave narrower cavities in the photoresist. When the substrate is etched, these differing widths translate into features in the substrate that have differing widths. The features have the same pitch, however, because the fringe spacing is not altered. This leads to a constant pitch, but a varying line:space ratio. This procedure provides a continuously decreasing channel width that may be accurately controlled over very long distances. Such gradient separation matrices exhibit the favorable traits of gradient gels (high resolution in separation), without the difficulty and irreproducibility associated with their preparation.
Similarly, this technique, when used with a negative photoresist, leaves wider features in the areas corresponding to fringes with weaker intensity and narrower features in the areas corresponding to fringes with stronger intensity.
An alternative approach may produce features with a gradient in width and pitch. This may be easily achieved with IL by using a cylindrical lens in one of the beams, while keeping the other beam as a plane wave. In this case the plane of exposure becomes a chord for a number of circular wavefronts. Because the wavefronts have different radii of curvature (spacing of an optical wavelength), the spacing between the interference fringes, as well as the width of the interference fringes, vary along the length of the plane containing the interference fringes on the surface of the photoresist coating the substrate. Similarly, curved surfaces (sections of Newton's rings) may be formed by interfering a plane wave and a spherical wave or two spherical waves of differing radii of curvature.
Other types of separation systems may involve discontinuous gradients. One such system may have differing aperture sizes that may be produced by separate exposures with different intensities, at different pitches through shadow masks, or by using multiple exposure techniques to eliminate rows and/or columns of pillars in certain areas of a previously exposed uniform nano-structured surface.
Variations in size may also be produced chemically. For example, increasing the oxidation of silicon in certain areas of a chip may result in a swelling of the features, reducing the width of some channels while conserving the pitch of the features. Similarly, macroscopic areas may be selectively functionalized with monolayers, reducing the width of channels in that area.
One may also electrochemically produce silicon carbide on a silicon substrate. Silicon carbide is suitable for sublimation growth, allowing one to control the width of the modified channels in a certain area. Of course, silicon carbide is only one example of surface modifications that may be performed.
One may also selectively heat a substrate, bringing it close to its annealing temperature. At this time the substrate may be placed under a highly controlled stress. The subsequent strain alters the size of channels. A gradient in temperature across the substrate results in a gradient of strain, and therefore a gradient in channel widths. This technique would only be suitable for substrates without a crystalline structure (such as glass or amorphous silicon, for example).
The very high aspect ratios of
Nanostructures that exhibit a gradient in their capacity to transport biomolecular species (through size exclusion or otherwise) may be created by the IL processes discussed herein. Such gradients make separation matrices feasible for highly efficient separation of molecular species. Molecular species may be driven in the direction of the gradient, and thus separated based on their tendency to traverse the gradient, by a variety of driving forces, including, but not limited to, electrophoresis, externally-applied pressure, capillarity, diffusion, and osmosis.
IL represents a convenient method for generating nanostructured separation matrices that contain physical gradients that allow selective transport of chemical species and, thus, may be used to achieve a separation of different chemicals. When compared to other nanolithographic methods of pattern generation (e.g., electron beam lithography, scanning probe lithography), IL is more convenient, efficient and inexpensive because it may be used to generate the entire pattern in one, parallel step and is not a serial “writing” technique. Other parallel techniques (e.g., imprint lithography) rely on a primary patterning technique to generate a master that may then be used to produce replicas of nanostructured features in a parallel fashion. While IL is a preferred method to generate nanostructured gradients for molecular separation, a variety of methods could be employed to generate the nanostructured matrix gradient “artificial gels” of the present invention. Gradients in the chemistry of the separation matrix may be prepared by a variety of methods as well, including those based on IL.
The use of IL allows such nanostructured separation matrices to be produced easily and very inexpensively. Nanostructures in which channels are on the order of the excluded size of dissolved biomolecules allow an enhanced flexibility in separation. Higher resolution may be obtained in combination with any of the following mechanisms namely, size exclusion, electrophoretic mobility, isoelectric point, asymmetric diffusion, entropic trapping, hydrophobic interaction and affinity interaction (molecular recognition), as well as others. The gradient matrices produced allow efficient separation and identification of biomolecules such as native proteins and protein complexes in addition to denatured proteins and nucleic acids.
Nanolithography-generated systems have advantages over conventional systems in terms of (1) the virtually perfect uniformity of pore size and pore size distribution from device to device, and (2) the flexibility to precisely define the required distribution (gradient) of pore sizes and pore chemistries. This high degree of reproducibility and versatility in nanofabrication will result in the ability to construct separation devices that exhibit unprecedented degrees of flexibility (resolution, dynamic range) and reproducibility in their separation characteristics.
The separation gradient may be formed by a variety of means including, for example, nanolithography (e.g., IL, electron beam, local probe, nanoimprint) and pattern transfer (etching, deposition, lift-off) means.
Multiple-exposure IL moiré patterns provide for cyclic gradients that may be used for simultaneous manufacture of multiple structures. Gradients may also be fabricated across uniform patterns by non-uniform deposition or etching using properly designed deposition and/or etching tools and techniques such as oblique incidence of etch/deposition atomic/molecular species (shadowing). Analogous techniques may be used in generation of gradients in surface modification chemistry incorporated into the array.
As an example of channel formation according to the present invention, IL and anisotropic wet etching of Si allow the creation of open, parallel nanostructured channels (e.g., uncapped in the direction perpendicular to the surface) with lateral features on the order of biomolecular length scales (˜1-10 nm) but with overall dimensions reaching the microscopic (˜100 μm) or even macroscopic (˜1 cm or greater) scales. Depending upon the dimensions, molecular transport mechanisms may include diffusion, electrophoresis or bulk-flow. The relatively large vertical scale is sufficient to allow high throughput of molecules and external pumping using either electrokinetic or electro-osmotic forces. Examples of high aspect ratio IL nanostructured samples are shown in
Arrays of nanostructures (either of uniform size or with a gradient of sizes) may be surface-modified with chemical species that enhance the separation characteristics of the matrix. These chemical species may be distributed uniformly formly over the nanostructured separation matrix or may be distributed in a gradient (continuous or discrete) in the direction of separation over the matrix. These chemical species may include small organic molecules, polymers, receptors or other biomolecules.
IL may be used to expose patterns on photoresist on silicon or other materials (which may later be etched). Silicon and some other materials may have an oxide surface that is easily modified with silanization reagents. Synthetic strategies for modification are also available for other materials (besides oxides), including native silicon and noble metals (e.g., gold). Monomolecular layers may be created from a wide range of commercially- or synthetically-available chemical species that may enhance separation characteristics based on the type and degree of interaction of chemical species being separated with the walls of the surface-modified nanostructured separation matrix. Examples of types of surface modifications (either as gradients or uniform) include the use of hydrophilic oligomeric and polymeric species (e.g., poly-ethylene glycol (PEG)) to minimize interactions of chemical species, especially proteins, with nanostructured surfaces; use of hydrophobic molecular or oligomeric species to elicit hydrophobic interaction of chemical species (especially proteins) with nanostructured surfaces; use of mixtures of hydrophobic and hydrophilic species (polar, apolar, H-bonding, ionic) to tune interaction of different chemical species with surfaces; use of ionic molecular species and mixtures of ionic species to tune interaction of different chemical species with surfaces; use of biomolecular or organic receptors to elicit molecular recognition of small molecules, polymers, proteins, DNA, RNA, or oligonucleotides with the surface; use of oligonucleotide probes to tune interactions of DNA, RNA or nucleic-acid binding proteins with the surface; use of cyclodextrins, macrocyclic antibiotics, crown ethers and other chiral selectors to tune enantiomeric interactions of chemical species with the surface; and use of stimuli-responsive (smart) molecules or polymers to allow external control of interaction of chemical species with the nanostructured surface.
Other types of separation systems of the present invention may be thought of as having discontinuous gradients. These separation systems contain areas with different aperture sizes, and may be made either by separate exposures at different intensity, at different pitches through shadow masks, or by using multiple exposure techniques to eliminate rows and/or columns of pillars. Such systems are especially useful in that they will allow recovery of separated compounds (purification).
Microfabricated Integrated Multi-Dimensional, Multi-Technique Separation Systems
The present invention allows a variety of different separation strategies (electrophoresis, iso-electric focusing, affinity chromatography, hydrophobic interaction chromatography, enantiomeric resolution) to be used on a single monolithic device, thus allowing for ease of use and compactness of instrumentation.
The closest existing commonly used multi-technique separation is two-dimensional gel electrophoresis (2DGE). In traditional 2DGE, proteins are first separated according to isoelectric point, followed by resolution by mass-to-charge-ratio using standard polyacrylamide electrophoresis. This process requires that two separate electrophoretic procedures be performed, each requiring manipulation of the sample. A nanostructured matrix of the present invention allows for sequential analysis on a single chip, thus reducing sample loss and diffusion. The wide range of chemical modifications and array architecture allowed by IL devices will also permit separation of proteins by means in addition to size and isoelectric point, either by appropriate chemical patterning and valving of the device, or by addition of a third separation and/or dilution dimension.
Fabrication of separation matrix systems from materials (e.g., Si and quartz) commonly used in the fabrication of integrated circuits is advantageous. They have unique etching and surface modification characteristics that are well established, and may be easily implemented in existing microfabrication facilities for the development of complex separation and detection systems. Other materials with advantageous characteristics may also be used.
The nanostructured matrix of the present invention may be used for two-dimensional gel electrophoresis, and a number of other separation techniques may be combined with size exclusion and/or isoelectric focusing. In addition, the matrix has the capability of expansion beyond two dimensions.
Combining two or more standard types of analysis on a single platform may enhance the analytical potential of a nanostructured matrix of the present invention. Among the possible combinations of separation technologies applicable to this platform are those analogous to PAGE, isoelectric focusing, hydrophobic interaction chromatography, affinity chromatography, enantiomeric resolution and capillary electrophoresis. The matrix lends itself well to carrying out equivalent molecular weight separations, with either electrical currents or flow as the driving force.
The present invention may be useful in proteomics by enabling combinations of different types of analysis, e.g., size exclusion in one dimension with chemical differentiation in the second. A third dimension, oriented perpendicular to the two dimensional array, may then be used for further separation, or for recovery and further characterization of isolated spots.
The present invention may also find use in protein separations for forensic and medical diagnostic tools and in the separation of bioengineered proteins. Forensic analysis and diagnostics, for example, depend heavily upon differentiation between carbohydrate moieties on blood proteins and bacterial cells. Discovery of clinically useful drugs often depends on identifying interactions with specific cellular receptors, which are usually glycoproteins. Capillary electrophoresis has been extremely useful in separations of acid carbohydrates, with derivatization of the column. The present invention allows for the separation of two properties, for example glycoprotein size and carbohydrate content on a single platform, thus eliminating the need for cumbersome recovery between steps and increasing the yield of useful analyte.
Recently, techniques utilizing antibody-based affinity separations have transitioned from clinical laboratories to those for environmental monitoring. The present invention allows sequential analysis of at least two different properties, thus increasing sensitivity of analysis, with particular interest for environmental monitoring.
The present invention allows for separation of a variety of sizes of nucleic acid species, and thus, may be used for separations that are currently done by standard and pulsed-field gel electrophoresis, as well as nucleic acid sequencing. In addition, modification of the device by nucleic acid-binding molecules (e.g., proteins, drugs) allows for isolation of relevant target sequences from previously uncharacterized genomes, or for isolation of a biocomplex formed with a nucleic acid. Because separation may be multidimensional, these devices may be attached in series with a reaction chamber (for example, a PCR thermocycler) and the resultant product directly fed into the separation platform for purification and analysis in a single device.
IL may be used to create nanostructures on a variety of substrates. IL, in combination with other standard lithographic and microfabrication methodologies, may be used to create a variety of nanostructures that may be modified in many ways to produce tools for separation of relevant biomolecules. These have advantages over contemporary molecular separation systems because they exhibit superior performance (resolution, sensitivity, dynamic range, applicability, reproducibility), may be parallel-produced at relatively low cost, and are extremely flexible in terms of chemical modifications. They have defined features that may be reproducibly made, enable flexible and complex separation, and may be used with existing bioseparation and detection strategies.
Supported and Suspended Lipid Bilayers on Nanotextured Surfaces
An additional aspect of the present invention is the use of defined lithographic nanostructures to suspend or support lipid bilayers and hybrid lipid bilayers as a separation platform for membrane-associated biomolecules. This invention expands upon previous methods for (1) incorporating lipid bilayers and nanostructured surfaces for separation techniques, and (2) creating lipid bilayers in which regions of the lipid bilayers are freely suspended or supported between two aqueous reservoirs. Specifically, the present invention utilizes suspended or supported lipid bilayer architecture in the separation of transmembrane molecules.
Of particular interest are nanofabricated arrays of structures that exhibit a gradient in their capacity to transport molecules. The reason being that such gradients allow for separation matrices that eliminate the requirement for detergent solubilization, and thus denaturation, of transmembrane biomolecules prior to separation, which is the current state of the art. Such gradient structures allow molecular species to be driven in the direction of the gradient, thereby separating the molecules based on their tendency to traverse the gradient. Molecular species may be driven across the gradient by forces such as electrophoresis, externally-applied pressure, capillarity, diffusion, and osmosis. Depending on the desired means of separation, several modifications of the nanostructured support that will enhance separation within the supported or suspended bilayer are envisioned. These include, but are not limited to chemical modifications, such as changes in hydrophobicity, charge, or dipole moment which will allow interactions with protein domains exterior to the bilayer, modification with ligands or other biomolecules that have the potential for interacting with a target class of membrane proteins, and other modifications that end users will deem necessary to base separations on membrane protein function.
Two relevant methods for fabricating suspended lipid bilayers have been reported: (1) suspending small unilamellar vesicles that are made and applied directly to an unmodified Si surface, and (2) generating large unilamellar vesicles with direct pipetting of these structures onto a surface. See, Groves, J. T., Wulfing, C., and Boxer, S. G., Electrical manipulation of glycan phosphatidyl inositol tethered proteins in planar supported bilayers, Biophysical Journal, 71: 2716-2723 (1996), and Menger, F. M., and Angelova, M. I., Accounts of Chemical Research, 31: 789-797 (1999), the entire contents and disclosures of which are hereby incorporated by reference. Preliminary studies included forming suspended lipid bilayers to examine their applicability in the present invention.
Since the electrophoretic mobility of transmembrane molecules across suspended lipid bilayers depends on (1) the molecule's mass to charge ratio, and (2) the size of the extramembrane domains relative to the corrugated apertures in the nanostructured support, it is necessary to fabricate a device that allows for preferential movement of molecules. An embodiment of the present invention suspends lipid bilayer membranes over a series of small gaps, approximately 100 nm in size, and utilizes the entire supported membrane as a separation and analysis platform. The small sizes of the gaps between features allows the lipid bilayer membrane to be suspended over the gaps, which allows for preferential movement of membrane phospholipids, transmembrane proteins, and other lipophilic biomolecules, and their complexes. More specifically, the relative fluidity of the lower leaflet of the lipid bilayer in the suspended regions, and resultant lack of steric hindrance of extramembrane protein domains, results in greater mobility of transmembrane molecules. Furthermore, by making the aperture size on the order of the molecular size of the transmembrane molecules, separations may be based on molecular filtering mechanisms in addition to electrophoretic mobility. Because the areas scanning the gaps may be supported on the underside by aqueous media, more room may also be available for intercellular domains. In addition, biophysical studies both of interactions between extra and intercellular domains of a single protein, and/or of interactions between intercellular domains of proteins within the same membrane are provided by the present invention. Thus, suspended lipid bilayer membranes offer several advantages over the current state of the art, particularly in regard to the separation and concentration of transmembrane proteins.
In a modification of the suspended lipid bilayer model, alkane-chain terminated self-assembled monolayers may be formed on the top surfaces of the nanostructured surfaces, either by silane modification of Si substrates or ω-substitued ω-substituted alkanethiols on, for example, gold. It is anticipated that these structures may provide even greater mobility of lipophilic biomolecules in supported and non-supported regions of the lipid bilayer membrane due to the immobility of the chemically fixed lower leaflet in the hybrid region.
Several nanotextured surfaces have also been explored. IL may produce a variety of features, including posts and grooves, in nearly infinite combinations of types and arrangements. Such features may be arranged in a regular array, thus mimicking standard gels, with the features either shaped or arranged in an asymmetric manner, or as semidiscontinuous, or chirped, arrays that vary in their size and/or separation distance along the direction of separation. Furthermore, a combination of grooves and/or posts may be arranged to achieve configurations that allow for two-dimensional separations. The present invention may be used for separation of membranes from osmotically disrupted cells (cell ghosts). This is particularly significant because no previous isolation of membrane-associated biomolecules is necessary, thus preserving the biomolecules' native conformations and complexes.
Although the present invention is primarily concerned with the structures described above, the nanostructured surfaces and lipid bilayer membranes may be combined in such a way to modify only the tops of the features, the lower surface of the nanostructured surface, the sides of the features, or any combination thereof. In addition, lipid bilayer membranes containing different molecules, or derived from different organelles within a cell, may be patterned on the nanostructured surface, thereby conferring a certain level of selectivity within the membrane itself, either due to innate properties of the molecules or the presence of interactive biomolecules within a region of the pattern. Thus, the present invention may be utilized in several manners to facilitate the study of biomolecules.
For instance, the nanostructured surfaces supporting lipid bilayer membranes may be utilized in biophysics to study membrane components. Because, within the suspended regions, neither leaflet of the membrane may be immobilized on the surface, total membrane fluidity may be increased, thus allowing for greater mobility of embedded biomolecules and creating an experimental milieu more closely replicating that found in the cell. Furthermore, interactions between cytoplasmic and extracellular domains may be more easily studied.
In addition, the present device shows promise as a biosensor device. Because the structure allows for proper orientation of the intercellular domains of transmembrane proteins, natural or engineered receptor proteins may take advantage of naturally occurring transduction mechanisms to facilitate signal transduction.
The present invention may further be useful in purification. The nanostructured lipid bilayer device may provide a unique platform on which to purify lipophilic membrane biomolecules. Because the components may be applied from membrane cell ghosts or in lipid micelles, the need for harsh and possibly denaturing detergent extraction may be unnecessary. In addition, complexes of associated proteins may be purified intact, thereby improving the study of pharmaceutical agents.
The present device may also be useful in the crystallization of membrane proteins to provide more pertinent information as to the structure and function of the proteins. The nanostructured lipid bilayer device may be manufactured to produce a gradient of features so that the protein in question aggregates at a single band in the device, thereby accumulating at the critical concentration.
Finally, the present invention may allow for greater flexibility in screening potential pharmaceutical agents. The nanostructured lipid bilayer device may facilitate observation of interactions between target transmembrane molecules and potential therapeutic agents within a defined membrane milieu, as well as allow for in vitro study of the resultant interactions between the drug-bound receptor and other components within the target complexes.
The present invention allows for unprecedented advances in the study of biomembranes and their associated molecules. The fact that membrane associated biomolecules may be applied to the present device, either via cell ghosts or vesicles, without first isolating them in aqueous media using detergent solubilization means that native configurations, associations and, thus, functionality may be preserved.
Design and construction of microscale electrophoresis cells incorporated much of the characteristics of the present invention into a compact system. The cell preferably has the following characteristics: (1) electrochemical current and fluid flow is restricted to occur only through the separation matrix; (2) loading and stacking functions are included; (3) monitoring of mobility and biomolecular detection is possible (e.g., through fluorescence imaging); and (4) for certain applications, separated compounds are recoverable. Simple methods have been used for incorporating nanostructured silicon/silica chips into electrophoresis cells that satisfy criteria (1-3) above. For example, simple methods of rapid prototyping of elastomeric gasket materials have been used.
Supported phospholipid bilayers (SPBs) of egg phosphatidyl choline (Egg PC) were formed by vesicle fusion on nanostructured silicon wafers containing troughs −180 nm in width on a 360 nm pitch. An intercalating dye was introduced, and the membranes were imaged by scanning laser microscopy. The resultant fluorescence micrographs indicated that the SPBs formed uniformly over the surface and simple FRAP measurements indicated that the bilayers were fluid and that recovery of fluorescence was preferentially in the direction parallel to the nanotroughs.
Transmembrane or membrane associated proteins may be incorporated into an SPB, from incorporation in the vesicle stage, insertion on the membrane or through incorporation of cell ghosts (i.e., intact membranes isolated from cells or organelles). The architecture and/or chemistry of the underlying nanotextured support would be then used to guide the movement of membrane proteins through the supported or suspended bilayer, either by size exclusion of the trough over which the membrane is supported, or by chemical interactions with modifications on the nanostructured support.
Although the present invention has been fully described in conjunction with the preferred embodiment thereof with reference to the accompanying drawings, it is to be understood that various changes and modifications may be apparent to those skilled in the art. Such changes and modifications are to be understood as included within the scope of the present invention as defined by the appended claims, unless they depart therefrom.
Brueck, Steven R. J., Lopez, Gabriel P., Ista, Linnea K.
Patent | Priority | Assignee | Title |
10081014, | Sep 27 2002 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
10107726, | Mar 16 2016 | CellMax, Ltd.; CellMax, Ltd | Collection of suspended cells using a transferable membrane |
10112198, | Aug 26 2014 | Academia Sinica | Collector architecture layout design |
10495644, | Apr 01 2014 | Academia Sinica | Methods and systems for cancer diagnosis and prognosis |
10605708, | Mar 16 2016 | CellMax, Ltd | Collection of suspended cells using a transferable membrane |
11052392, | Sep 27 2002 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
11674958, | Jun 29 2011 | Academia Sinica | Capture, purification, and release of biological substances using a surface coating |
8372579, | Sep 27 2002 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
8961764, | Oct 15 2010 | ABACUS INNOVATIONS TECHNOLOGY, INC ; LEIDOS INNOVATIONS TECHNOLOGY, INC | Micro fluidic optic design |
9067207, | Jun 04 2009 | ABACUS INNOVATIONS TECHNOLOGY, INC ; LEIDOS INNOVATIONS TECHNOLOGY, INC | Optical approach for microfluidic DNA electrophoresis detection |
9322054, | Feb 22 2012 | ABACUS INNOVATIONS TECHNOLOGY, INC ; LEIDOS INNOVATIONS TECHNOLOGY, INC | Microfluidic cartridge |
9541480, | Jun 29 2011 | Academia Sinica | Capture, purification, and release of biological substances using a surface coating |
9649631, | Jun 04 2009 | ABACUS INNOVATIONS TECHNOLOGY, INC ; LEIDOS INNOVATIONS TECHNOLOGY, INC | Multiple-sample microfluidic chip for DNA analysis |
9656261, | Jun 04 2009 | ABACUS INNOVATIONS TECHNOLOGY, INC ; LEIDOS INNOVATIONS TECHNOLOGY, INC | DNA analyzer |
9988676, | Feb 22 2012 | ABACUS INNOVATIONS TECHNOLOGY, INC ; LEIDOS INNOVATIONS TECHNOLOGY, INC | Microfluidic cartridge |
Patent | Priority | Assignee | Title |
3855133, | |||
3906929, | |||
4190535, | Feb 27 1978 | BECTON DICKINSON AND COMPANY, A CORP OF NEW JERSEY | Means for separating lymphocytes and monocytes from anticoagulated blood |
4737268, | Mar 18 1986 | University of Utah | Thin channel split flow continuous equilibrium process and apparatus for particle fractionation |
4801380, | Dec 23 1987 | The Texas A&M University System | Method of producing a silicon film with micropores |
4814082, | Oct 20 1986 | Memtec America Corporation | Ultrafiltration thin film membranes |
4814088, | Aug 28 1985 | National Research Council of Canada | Method for the molecular filtration of predominantly aliphatic hydrocarbon liquids |
4902424, | Oct 26 1986 | Memtec America Corporation | Ultrafiltration thin film membranes |
4906439, | Mar 25 1986 | Behringwerke AG | Biological diagnostic device and method of use |
4915839, | Mar 15 1984 | Cuno, Incorporated | Process for surface modifying a microporous membrane |
4916110, | Nov 01 1988 | W L GORE & ASSOCIATES, INC | Microporous catalytic material and support structure |
4935141, | Aug 31 1987 | Gambro Dialysatoren GmbH | Selectively permeable asymmetric membranes suitable for use in hemodialysis and processes for manufacturing such membranes |
4969998, | Apr 23 1984 | W L GORE & ASSOCIATES, INC | Composite semipermeable membrane |
4971904, | Jun 26 1987 | E I DU PONT DE NEMOURS AND COMPANY, WILMINGTON, DE A CORP OF DE | Heterogeneous immunoassay |
4977078, | Dec 22 1987 | Olympus Optical Co., Ltd. | Plate substrate immunoassay device and method for performing a multi-test immunoassay on a specimen |
5013337, | Dec 06 1988 | UOP | Process for separating a mixture of molecular species using crystalline microporous metal sulfide compositions |
5019263, | Jun 05 1990 | Mobil Oil Corp. | Membrane composed of a pure molecular sieve |
5130025, | Apr 20 1978 | Unisearch Limited | Membrane separation and purification of compounds |
5131998, | Nov 13 1990 | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, THE, CHAPEL HILL, COUNTY OF ORANGE, NC A CONSTITUENT INSTITUTION OF NC | Two-dimensional high-performance liquid chromatography/capillary electrophoresis |
5145584, | Dec 05 1990 | Allied-Signal Inc.; ALLIED-SIGNAL INC , A CORPORATION OF DELAWARE | Processes for using a thin film composite ultrafiltration membrane |
5147606, | Aug 06 1990 | Miles Inc. | Self-metering fluid analysis device |
5193688, | Dec 08 1989 | University of Utah | Method and apparatus for hydrodynamic relaxation and sample concentration NIN field-flow fraction using permeable wall elements |
5204239, | Jan 09 1990 | YEDA RESEARCH AND DEVELOPMENT CO LTD | Biosensors including lipid bilayer doped with ion channels anchored to a recording electrode by bridging molecules |
5266207, | Apr 30 1991 | TECHSEP | Composite nanofiltration membrane |
5296375, | May 01 1992 | Trustees of the University of Pennsylvania | Mesoscale sperm handling devices |
5304487, | May 01 1992 | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, A CORP OF PA | Fluid handling in mesoscale analytical devices |
5427663, | Jun 08 1993 | BTG INTERNATIONAL INC | Microlithographic array for macromolecule and cell fractionation |
5427946, | May 01 1992 | Trustees of the University of Pennsylvania | Mesoscale sperm handling devices |
5474675, | Nov 17 1988 | Herco-CFF ChiralFlow Filtertechnik GmbH | Filter separator for separating a composite fluid |
5500071, | Oct 19 1994 | Agilent Technologies Inc | Miniaturized planar columns in novel support media for liquid phase analysis |
5541072, | Apr 18 1994 | Veridex, LLC | Method for magnetic separation featuring magnetic particles in a multi-phase system |
5587070, | Nov 06 1990 | HAEMONETICS PUERTO RICO, LLC | System for processing biological fluid |
5622831, | Sep 26 1990 | Janssen Diagnostics, LLC | Methods and devices for manipulation of magnetically collected material |
5637458, | Jul 20 1994 | Sios, Inc. | Apparatus and method for the detection and assay of organic molecules |
5639669, | Jun 07 1995 | Separation of fetal cells from maternal blood | |
5646048, | Jul 24 1995 | Agilent Technologies Inc | Microcolumnar analytical apparatus with microcolumnar flow gating interface and method of using the apparatus |
5674592, | May 04 1995 | Minnesota Mining and Manufacturing Company | Functionalized nanostructured films |
5707799, | Sep 30 1994 | Abbott Laboratories | Devices and methods utilizing arrays of structures for analyte capture |
5709943, | May 04 1995 | Minnesota Mining and Manufacturing Company | Biological adsorption supports |
5715946, | Jun 07 1995 | Method and apparatus for sorting particles suspended in a fluid | |
5716527, | Jul 08 1994 | EXXON RESEARCH & ENGINEERING CO | Zeolite membrane with a selectivity enhancing coating |
5728457, | Sep 30 1994 | Cornell Research Foundation, Inc. | Porous polymeric material with gradients |
5736342, | Sep 21 1993 | Washington State University Research Foundation | Biosensor for detecting the presence of chosen analytes |
5750339, | Nov 30 1994 | Thomas Jefferson University | Methods for identifying fetal cells |
5753014, | Nov 12 1993 | Membrane filter and a method of manufacturing the same as well as a membrane | |
5770029, | Jul 30 1996 | Monogram Biosciences, Inc | Integrated electrophoretic microdevices |
5798042, | Mar 07 1994 | CALIFORNIA, THE UNIVERSITY OF, REGENTS OF, THE | Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters |
5837115, | Jun 08 1993 | BTG INTERNATIONAL INC | Microlithographic array for macromolecule and cell fractionation |
5843767, | Oct 28 1993 | UT-Battelle, LLC | Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions |
5858188, | Feb 28 1990 | Monogram Biosciences, Inc | Acrylic microchannels and their use in electrophoretic applications |
5858195, | Aug 01 1994 | Lockheed Martin Energy Research Corporation | Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis |
5866345, | May 01 1992 | The Trustees of the University of Pennsylvania | Apparatus for the detection of an analyte utilizing mesoscale flow systems |
5871650, | Jul 08 1994 | EXXON RESEARCH & ENGINEERING CO | Supported zeolite membranes with controlled crystal width and preferred orientation grown on a growth enhancing layer |
5876830, | Sep 08 1995 | Board of Regents of the University of Colorado | Method of assembly of molecular-sized nets and scaffolding |
5891651, | Mar 29 1996 | Mayo Foundation for Medical Education and Research | Methods of recovering colorectal epithelial cells or fragments thereof from stool |
5922591, | Jun 29 1995 | AFFYMETRIX, INC A DELAWARE CORPORATION | Integrated nucleic acid diagnostic device |
5928880, | May 01 1992 | Trustees of the University of Pennsylvania | Mesoscale sample preparation device and systems for determination and processing of analytes |
5935822, | Mar 21 1995 | Regents of the University of Colorado, The | Product and process for membrane and soluble polypeptide segregation |
5938923, | Apr 15 1997 | Regents of the University of California, The | Microfabricated filter and capsule using a substrate sandwich |
5993661, | Apr 14 1997 | The Research Foundation of State University of New York | Macroporous or microporous filtration membrane, method of preparation and use |
6007690, | Jul 30 1996 | Monogram Biosciences, Inc | Integrated microfluidic devices |
6022590, | Jul 14 1994 | Competitive Technologies, Inc. | Stepwise formation of multilayered nanostructures from macromolecular precursors |
6033546, | Aug 01 1994 | Lockheed Martin Energy Research Corporation | Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis |
6043177, | Jan 21 1997 | University Technology Corporation | Modification of zeolite or molecular sieve membranes using atomic layer controlled chemical vapor deposition |
6044981, | Mar 07 1994 | The Regents of the University of California | Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters |
6051372, | Sep 09 1997 | Nimbus Biotechnologie GmbH | Template induced patterning of surfaces and their reversible stabilization using phase transitions of the patterned material |
6051517, | Jan 21 1997 | University Technology Corp. | Modified zeolite membrane |
6054034, | Feb 28 1990 | Monogram Biosciences, Inc | Acrylic microchannels and their use in electrophoretic applications |
6060415, | Feb 10 1997 | National Science Council | Aligned molecular sieve crystals grown on anodic alumina membrane |
6074827, | Dec 02 1997 | Monogram Biosciences, Inc | Microfluidic method for nucleic acid purification and processing |
6090289, | Jul 08 1994 | Exxon Research and Engineering Company | Molecular sieves and processes for their manufacture |
6100393, | Mar 15 1996 | Antibioticos, S.A. | Process for purifying 7-substituted aminodeacetoxy-cephalosporins through the use of filtration membranes |
6113794, | Jan 25 1999 | National Research Council of Canada | Composite solvent resistant nanofiltration membranes |
6113795, | Nov 17 1998 | KANSAS, UNIVERSITY OF, THE | Process and apparatus for size selective separation of micro- and nano-particles |
6132607, | Feb 20 1998 | FLORIDA STATE UNIVERSITY, THE | System for continuous magnetic separation of components from a mixture |
6143576, | May 21 1992 | BIOSITE, INC | Non-porous diagnostic devices for the controlled movement of reagents |
6156270, | May 21 1992 | BIOSITE, INC | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
6177373, | Mar 14 1996 | Exxon Chemicals Patents INC | Procedure for preparing molecular sieve films |
6187446, | Mar 29 1995 | LAURELL, THOMAS | Carrier matrix for integrated microanalysis systems, method for the production thereof and use of the same |
6190638, | Jan 04 1996 | Exxon Chemical Patents Inc. | Molecular sieves and process for their manufacture |
6197523, | Nov 24 1997 | LEVINE, ROBERT A ; WARDLAW, STEPHEN C | Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood |
6200765, | May 04 1998 | Pacific Northwest Cancer Foundation | Non-invasive methods to detect prostate cancer |
6210570, | Aug 21 1998 | Agilent Technologies Inc | Monolithic silica column |
6241894, | Oct 10 1997 | Systemix | High gradient magnetic device and method for cell separation or purification |
6251691, | Apr 25 1996 | BIOARRAY SOLUTIONS LTD | Light-controlled electrokinetic assembly of particles near surfaces |
6261928, | Jul 22 1997 | Commissariat a l 'Energie Atomique | Producing microstructures or nanostructures on a support |
6264044, | Apr 11 1997 | 3M Innovative Properties Company | Reinforced, three zone microporous membrane |
6265229, | Mar 10 1994 | SHENZHEN XINGUODU TECHNOLOGY CO , LTD | Method and device for detection of specific target cells in specialized or mixed cell populations and solutions containing mixed cell populations |
6277489, | Dec 04 1998 | Regents of the University of California, The | Support for high performance affinity chromatography and other uses |
6309798, | May 08 1996 | Studiengesellschaft Kohle mbH | Lithographical process for production of nanostructures on surfaces |
6315940, | Nov 16 1996 | Cytocentrics AG | Microelement device |
6329209, | Jul 14 1998 | ZYOMYX, INC | Arrays of protein-capture agents and methods of use thereof |
6344326, | Jul 30 1996 | Monogram Biosciences, Inc | Microfluidic method for nucleic acid purification and processing |
6361958, | Nov 12 1999 | OSMETECH TECHNOLOGY INC | Biochannel assay for hybridization with biomaterial |
6368871, | Aug 13 1997 | Cepheid | Non-planar microstructures for manipulation of fluid samples |
6383759, | May 04 1998 | GERALD P MURPHY CANCER FOUNDATION | Non-invasive method to detect prostate cancer |
6387290, | Jun 16 1995 | University of Washington | Tangential flow planar microfabricated fluid filter |
6432630, | Sep 04 1996 | Inverness Medical Switzerland GmbH | Micro-flow system for particle separation and analysis |
6444461, | Apr 04 1997 | Caliper Technologies Corp. | Microfluidic devices and methods for separation |
6450047, | Nov 09 1998 | Agilent Technologies, Inc. | Device for high throughput sample processing, analysis and collection, and methods of use thereof |
6454938, | Sep 17 1998 | GEFUS SBIC II, L P | Integrated monolithic microfabricated electrospray and liquid chromatography system and method |
6465225, | Jun 29 1998 | Evotec Technologies GmbH | Method and device for manipulating particles in microsystems |
6491823, | Apr 03 1998 | Intermolecular, Inc | Targeted separation protocols for rapid characterizations of polymers |
6503452, | Nov 29 1996 | BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, THE | Biosensor arrays and methods |
6540895, | Sep 23 1997 | California Institute of Technology | Microfabricated cell sorter for chemical and biological materials |
6570196, | Mar 22 2000 | MAX-PLANK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E V | Lipid vesicles or lipid bilayers on chips |
6576478, | Jul 14 1998 | ADVANCED BIOINTEGRATED TECHNOLOGIES, INC ; ZYOMYX, INC | Microdevices for high-throughput screening of biomolecules |
6582969, | Jul 14 1998 | Zyomyx, Inc. | Microdevices for high-throughput screening of biomolecules |
6596144, | May 27 1997 | Purdue Research Foundation | Separation columns and methods for manufacturing the improved separation columns |
6596545, | Jul 14 1998 | ZYOMYX, INC | Microdevices for screening biomolecules |
6613525, | Jul 30 1996 | Monogram Biosciences, Inc | Microfluidic apparatus and method for purification and processing |
6632619, | May 16 1997 | ZELLCHIP TECHNOLOGIES INC | Microfluidic system and methods of use |
6635163, | Jun 01 1999 | Cornell Research Foundation, Inc. | Entropic trapping and sieving of molecules |
6641997, | Mar 20 1998 | ROCKEFELLER UNIVERSITY, THE | Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof |
6664104, | Dec 24 1998 | Cepheid | Device incorporating a microfluidic chip for separating analyte from a sample |
6685841, | Feb 14 2001 | STC UNM | Nanostructured devices for separation and analysis |
6746503, | Jan 30 2003 | Lawrence Livermore National Security LLC | Precision gap particle separator |
6762059, | Aug 13 1999 | U S GENOMICS, INC | Methods and apparatuses for characterization of single polymers |
6783647, | Oct 19 2001 | UT-Battelle, LLC | Microfluidic systems and methods of transport and lysis of cells and analysis of cell lysate |
6794148, | Jun 26 1995 | Applied Biosystems, LLC | High speed, automated, continuous flow, multi-dimensional molecular selection and analysis |
6815664, | Apr 27 2001 | PROGENITY, INC | Method for separation of particles |
6818184, | Aug 31 2000 | The Regents of the University of California | Capillary array and related methods |
6872522, | Jun 25 1996 | MECKLENBURG, MICHAEL | Broad specificity affinity arrays: a qualitative approach to complex sample discrimination |
6878271, | Sep 09 2002 | CYTONOME ST, LLC | Implementation of microfluidic components in a microfluidic system |
6881315, | Aug 03 2001 | NEC Corporation | Fractionating apparatus having colonies of pillars arranged in migration passage at interval and process for fabricating pillars |
6893881, | Sep 14 1992 | NORWEGIAN RADIUM HOSPITAL RESEARCH FOUNDATION, THE | Method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations |
6911345, | Jun 28 1999 | California Institute of Technology | Methods and apparatus for analyzing polynucleotide sequences |
6913697, | Feb 14 2001 | STC UNM | Nanostructured separation and analysis devices for biological membranes |
6958245, | Apr 25 1996 | BIOARRAY SOLUTIONS LTD | Array cytometry |
6960449, | Feb 10 1999 | GPB Scientific, LLC | Class characterization of circulating cancer cells isolated from body fluids and methods of use |
7150812, | Oct 23 2002 | TRUSTEES OF PRINCETON UNIVERSITY, THE | Method for continuous particle separation using obstacle arrays asymmetrically aligned to fields |
20010036672, | |||
20020005354, | |||
20020058332, | |||
20020090741, | |||
20020108859, | |||
20020115163, | |||
20020115164, | |||
20020123078, | |||
20020123112, | |||
20020132315, | |||
20020132316, | |||
20020172987, | |||
20030072682, | |||
20030077292, | |||
20030159999, | |||
20040018116, | |||
20040072278, | |||
20040121343, | |||
20040144651, | |||
20040232074, | |||
20040245102, | |||
20050049793, | |||
20050092662, | |||
20050123454, | |||
20050142663, | |||
20050145497, | |||
20050164158, | |||
20050170373, | |||
20050170418, | |||
20050175996, | |||
20050191636, | |||
20050211556, | |||
20050236314, | |||
20050239101, | |||
20050244843, | |||
20050250111, | |||
20050250199, | |||
20050252840, | |||
20050262577, | |||
20050266433, | |||
20050282196, | |||
20060051265, | |||
20060060767, | |||
20060134599, | |||
20060160243, | |||
20060223178, | |||
20060252054, | |||
20060252087, | |||
20070026381, | |||
20070026413, | |||
20070026414, | |||
20070026415, | |||
20070026416, | |||
20070026417, | |||
20070026418, | |||
20070026419, | |||
20070026469, | |||
20070059680, | |||
20070059683, | |||
20070059716, | |||
20070059718, | |||
20070059719, | |||
20070059774, | |||
20070059781, | |||
20070099207, | |||
DE19712309, | |||
EP57907, | |||
EP94193, | |||
EP919812, | |||
EP1221342, | |||
EP1338894, | |||
EP1418003, | |||
EP1462800, | |||
WO62931, | |||
WO212896, | |||
WO228523, | |||
WO230562, | |||
WO3000418, | |||
WO3031938, | |||
WO3035894, | |||
WO3079006, | |||
WO3085379, | |||
WO2004004906, | |||
WO2004015411, | |||
WO2004024327, | |||
WO2004029221, | |||
WO2004037374, | |||
WO2004056978, | |||
WO2004113877, | |||
WO2005043121, | |||
WO2005047529, | |||
WO2005049168, | |||
WO2005058937, | |||
WO2005068503, | |||
WO2005084374, | |||
WO2005085861, | |||
WO2005108621, | |||
WO2005109238, | |||
WO2005121362, | |||
WO2006078470, | |||
WO9322053, | |||
WO9429707, | |||
WO9810267, | |||
WO9944064, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jul 01 2008 | STC.UNM | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |
Mar 29 2014 | 4 years fee payment window open |
Sep 29 2014 | 6 months grace period start (w surcharge) |
Mar 29 2015 | patent expiry (for year 4) |
Mar 29 2017 | 2 years to revive unintentionally abandoned end. (for year 4) |
Mar 29 2018 | 8 years fee payment window open |
Sep 29 2018 | 6 months grace period start (w surcharge) |
Mar 29 2019 | patent expiry (for year 8) |
Mar 29 2021 | 2 years to revive unintentionally abandoned end. (for year 8) |
Mar 29 2022 | 12 years fee payment window open |
Sep 29 2022 | 6 months grace period start (w surcharge) |
Mar 29 2023 | patent expiry (for year 12) |
Mar 29 2025 | 2 years to revive unintentionally abandoned end. (for year 12) |